Skip to main content
Year archive

CSPC Pharmaceutical Group Limited — 2020 filings

All 79 regulatory filings released by CSPC Pharmaceutical Group Limited (1093) in 2020, sourced directly from the official regulator.

79 Filings
2020 Period
2020 filings (79)
Filing Released Lang
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-12-31 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE OF COMPANY SECRETARY AND CHANGE OF BOARD COMMITTEES
Board/Management Information
2020-12-28 English
INSIDE INFORMATION - ADJUSTMENT TO THE MEDICAL INSURANCE REIMBURSEMENT BASIS
Regulatory Filings
2020-12-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2020-12-18 English
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT
Regulatory Filings
2020-12-18 English
VOLUNTARY ANNOUNCEMENT - ABSTRACT OF CLINICAL TRIAL DATA OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND EXTRANODAL NK/T-CELL LYMPHOMA PRESENTED A
Regulatory Filings
2020-12-18 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2020
Regulatory Filings
2020-12-02 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG NBL-015 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2020-12-02 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG "ALMB-0166" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2020-12-01 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Regulatory Filings
2020-11-24 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-11-24 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information
2020-11-23 English
QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020
Interim / Quarterly Report
2020-11-23 English
DATE OF BOARD MEETING
Regulatory Filings
2020-11-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2020
Share Issue/Capital Change
2020-11-04 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1813 ORAL SOLUTIONS" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2020-11-03 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-10-29 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE 1 CLINICAL TRIAL OF INVESTIGATIONAL NEW DRUG "ALMB-0168"
Regulatory Filings
2020-10-28 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2020
Interim / Quarterly Report
2020-10-22 English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 12 OCTOBER 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2020
Regulatory Filings
2020-10-05 English
PROXY FORM FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, 12 OCTOBER 2020 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2020-09-22 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-09-22 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF THE CIRCULAR DATED 23 SEPTEMBER 2020
Report Publication Announcement
2020-09-22 English
PROPOSAL FOR ISSUE OF BONUS SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-09-22 English
VOLUNTARY ANNOUNCEMENT - "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Regulatory Filings
2020-09-17 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2020 INTERIM REPORT
Report Publication Announcement
2020-09-17 English
INTERIM REPORT 2020
Interim / Quarterly Report
2020-09-17 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG "ALMB-0168" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Regulatory Filings
2020-09-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2020
Regulatory Filings
2020-09-01 English
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT
Regulatory Filings
2020-08-28 English
2020 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2020-08-27 English
2020 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2020-08-26 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR "MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION"
Regulatory Filings
2020-08-25 English
VOLUNTARY ANNOUNCEMENT - ONCOLOGY DRUG "SYHA1815 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2020-08-24 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD . FOR THE HALF YEAR ENDED 30 JUNE 2020
Interim / Quarterly Report
2020-08-20 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-14 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-08-14 English
RESIGNATION OF DIRECTOR
Board/Management Information
2020-08-14 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2020
Share Issue/Capital Change
2020-08-06 English
VOLUNTARY ANNOUNCEMENT - "DULOXETINE HYDROCHLORIDE ENTERIC CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-07-27 English
VOLUNTARY ANNOUNCEMENT - "MEMANTINE HYDROCHLORIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-07-21 English
VOLUNTARY ANNOUNCEMENT - "ACARBOSE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-07-21 English
2019 CORPORATE SOCIAL RESPONSIBILITY REPORT
Regulatory Filings
2020-07-20 English
VOLUNTARY ANNOUNCEMENT - "CELECOXIB CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-07-14 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-07-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2020
Share Issue/Capital Change
2020-07-02 English
VOLUNTARY ANNOUNCEMENT - "BORTEZOMIB FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-06-23 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 15 JUNE 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2020
Regulatory Filings
2020-06-01 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1805" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2020-05-28 English
INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES OR CHINESE DEPOSITARY RECEIPTS AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE
Capital/Financing Update
2020-05-27 English
QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2020
Interim / Quarterly Report
2020-05-27 English
VOLUNTARY ANNOUNCEMENT - "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL
Regulatory Filings
2020-05-19 English
DATE OF BOARD MEETING
Regulatory Filings
2020-05-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2020
Share Issue/Capital Change
2020-05-04 English
VOLUNTARY ANNOUNCEMENT - "ORNITHINE ASPARTATE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL
Regulatory Filings
2020-05-04 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 15 JUNE 2020 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2020-04-27 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2019 ANNUAL REPORT AND THE CIRCULAR DATED 28 APRIL 2020
Report Publication Announcement
2020-04-27 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-04-27 English
PROPOSALS FOR ISSUE OF BONUS SHARES, GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES AND MANDATE TO GRANT OPTIONS, RE-ELECTION OF THE RETIRING DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-04-27 English
2019 ANNUAL REPORT
Regulatory Filings
2020-04-27 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020
Interim / Quarterly Report
2020-04-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2020
Capital/Financing Update
2020-04-01 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Annual Report
2020-03-30 English
INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020
Regulatory Filings
2020-03-22 English
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Annual Report
2020-03-22 English
DATE OF BOARD MEETING
Regulatory Filings
2020-03-18 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "RIVAROXABAN TABLETS"
Regulatory Filings
2020-03-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2020
Major Shareholding Notification
2020-03-02 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "MONTELUKAST SODIUM TABLETS AND CHEWABLE TABLETS"
Regulatory Filings
2020-02-25 English
INSIDE INFORMATION - PRELIMINARY RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Earnings Release
2020-02-24 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0168 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA
Regulatory Filings
2020-02-24 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2020
Share Issue/Capital Change
2020-02-03 English
INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Regulatory Filings
2020-01-22 English
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
Regulatory Filings
2020-01-19 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "PRAMIPEXOLE DIHYDROCHLORIDE TABLETS"
Regulatory Filings
2020-01-02 English
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "SUNITINIB MALATE CAPSULES"
Regulatory Filings
2020-01-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2019
Share Issue/Capital Change
2020-01-02 English